Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection

被引:9
作者
Zhang, Yaowen [1 ]
Gao, Junhui [2 ]
Zheng, Anping [1 ]
Yang, Haijun [1 ]
Li, Jian [1 ]
Wu, Shouxin [2 ]
Zhao, Jiangman [2 ]
Meng, Peng [2 ]
Zhou, Fuyou [1 ]
机构
[1] Henan Univ Sci & Technol, Dept Radiat Oncol, Anyang Canc Hosp, Affiliated Hosp 4, Anyang 455000, Peoples R China
[2] Biotecan Pharmaceut Co Ltd, Shanghai Zhangjiang Inst Med Innovat, Shanghai 201204, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2021年 / 14卷 / 06期
基金
中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; Early recurrence; Esophagectomy; Minimum p-value; Post-relapse treatment; PROGRESSION-FREE SURVIVAL; CANCER; THERAPY; DEATH;
D O I
10.1016/j.tranon.2021.101066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Early recurrence after surgery could affect cancerous patients? prognosis, but the definition of early recurrence and its risk factors for esophageal squamous cell carcinoma (ESCC) patients are still unclear. This study analyzed the clinical data of 468 post-surgery recurrent ESCC patients retrospectively. A minimum p -value approach was used to evaluate the optimal cut-off value of recurrence free survival (RFS) to define early recurrence. Risk factors of early recurrence were developed based on a Cox model. The optimal cut-off value of RFS to distinguish early recurrence was 21 months ( p < 0.001). Independent risk factors for early recurrence included tumor locations (HR = 0.562, p < 0.001), pathological T stage (HR = 1.829, p < 0.001), tumor diameter (HR = 1.344, p = 0.039), positive lymph nodes (HR = 1.361, p < 0.001), and total resected lymph nodes (HR = 1.271, p = 044). For the late recurrent patients, there was a much more significant survival advantage for recurrence after concurrent chemoradiotherapy than that after sequential chemoradiotherapy and radiotherapy alone ( p = 0.0066). In conclusion, this study defined 21 months of RFS as early recurrence and also identified its risk factors. Concurrent chemoradiotherapy was suggested as preferred post-relapse treatment for late recurrent ESCC patients.
引用
收藏
页数:8
相关论文
共 26 条
  • [1] Epidemiology of Esophageal Squamous Cell Carcinoma
    Abnet, Christian C.
    Arnold, Melina
    Wei, Wen-Qiang
    [J]. GASTROENTEROLOGY, 2018, 154 (02) : 360 - 373
  • [2] Allemani C., GLOBAL SURVEILLANCE, V37, P513
  • [3] [Anonymous], 2018, LANCET, V391, P1023, DOI 10.1016/
  • [4] [Anonymous], 2018, ANN SURG
  • [5] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [6] Factors associated with early recurrence and death after esophagectomy for cancer
    Davies, Andrew R.
    Pillai, Andrew
    Sinha, Pranab
    Sandhu, Harinderjeet
    Adeniran, Amina
    Mattsson, Fredrik
    Choudhury, Asif
    Forshaw, Matthew J.
    Gossage, James A.
    Lagergren, Jesper
    Allum, William H.
    Mason, Robert C.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (05) : 459 - 464
  • [7] Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
    Groot, Vincent P.
    Gemenetzis, Georgios
    Blair, Alex B.
    Rivero-Soto, Roberto J.
    Yu, Jun
    Javed, Ammar A.
    Burkhart, Richard A.
    Rinkes, Inne H. M. Borel
    Molenaar, I. Quintus
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    [J]. ANNALS OF SURGERY, 2019, 269 (06) : 1154 - 1162
  • [8] Guo S.W., 2020, SURGERYSURGERY
  • [9] Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma
    Hamai, Yoichi
    Emi, Manabu
    Ibuki, Yuta
    Murakami, Yuji
    Nishibuchi, Ikuno
    Nagata, Yasushi
    Furukawa, Takaoki
    Kurokawa, Tomoaki
    Ohsawa, Manato
    Okada, Morihito
    [J]. ANTICANCER RESEARCH, 2019, 39 (03) : 1433 - 1440
  • [10] Late Recurrence After Radical Resection of Esophageal Cancer
    Hiyoshi, Yukiharu
    Yoshida, Naoya
    Watanabe, Masayuki
    Kurashige, Junji
    Karashima, Ryuichi
    Iwagami, Shiro
    Baba, Yoshifumi
    Baba, Hideo
    [J]. WORLD JOURNAL OF SURGERY, 2016, 40 (04) : 913 - 920